Key facts
- This page summarizes ATLAS VENTURE ASSOCIATES X, L.P.'s Form 4 filing for Generation Bio Co. (GBIO).
- 6 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Sep 2021, 19:15.
ATLAS VENTURE ASSOCIATES X, L.P. - 27 Sep 2021 Form 4 Insider Report for Generation Bio Co. (GBIO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- GBIO
- Reported as of
- 27 Sep 2021
- Net transaction value
- -$2,059,519
- SEC form
- 4
- Accepted by SEC
- 29 Sep 2021, 19:15:51 UTC
- Prior SEC filing
- 24 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- Atlas Venture Associates X, L.P., By: Atlas Venture Associates X, LLC, Its: General Partner, By: /s/ Ommer Chohan, Chief Financial Officer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
ATLAS VENTURE ASSOCIATES X, L.P. filed Form 4 for Generation Bio Co. (GBIO) on 29 Sep 2021.
Change
- Previous filing in this sequence was filed on 24 Sep 2021.
- Current net transaction value: -$2,059,519.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GBIO
transaction
Common Stock
Sale
- Transaction value
- $1,318,256
- Shares
- -51,294
- Change %
- -63%
- Price
- $25.70*
- Shares after
- 29,645
- Date
- 27 Sep 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3
GBIO
transaction
Common Stock
Sale
- Transaction value
- $2,442
- Shares
- -95
- Change %
- -13%
- Price
- $25.70*
- Shares after
- 662
- Date
- 27 Sep 2021
- Ownership
- See footnote
- Footnotes
- F1, F2, F4
GBIO
transaction
Common Stock
Sale
- Transaction value
- $330,366
- Shares
- -13,089
- Change %
- -44%
- Price
- $25.24*
- Shares after
- 16,556
- Date
- 28 Sep 2021
- Ownership
- Direct
- Footnotes
- F1, F3, F5
GBIO
transaction
Common Stock
Sale
- Transaction value
- $606
- Shares
- -24
- Change %
- -3.6%
- Price
- $25.24*
- Shares after
- 638
- Date
- 28 Sep 2021
- Ownership
- See footnote
- Footnotes
- F1, F4, F5
GBIO
transaction
Common Stock
Sale
- Transaction value
- $407,112
- Shares
- -16,556
- Change %
- -100%
- Price
- $24.59*
- Shares after
- 0
- Date
- 29 Sep 2021
- Ownership
- Direct
- Footnotes
- F1, F3, F6
GBIO
transaction
Common Stock
Sale
- Transaction value
- $738
- Shares
- -30
- Change %
- -4.7%
- Price
- $24.59*
- Shares after
- 608
- Date
- 29 Sep 2021
- Ownership
- See footnote
- Footnotes
- F1, F4, F6
GBIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,111,939
- Date
- 27 Sep 2021
- Ownership
- See footnote
- Footnotes
- F7
GBIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,166,937
- Date
- 27 Sep 2021
- Ownership
- See footnote
- Footnotes
- F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Shares were sold pursuant to a Rule 10b5-1 trading plan dated April 20, 2021.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $26.07 inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5) and (6).
Footnote F3
The shares are held directly by Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. AVA X LLC disclaims Section 16 beneficial ownership of the securities held by AVA X LP except to the extent of its pecuniary interest therein, if any.
Footnote F4
The shares are held directly by Atlas Venture Associates Opportunity I, LP ("AVAO LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. AVAO LLC disclaims Section 16 beneficial ownership of the securities held by AVAO LP except to the extent of its pecuniary interest therein, if any.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.93 to $25.79 inclusive.
Footnote F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.46 to $25.36 inclusive.
Footnote F7
The shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is AVA X LP. AVA X LLC is the general partner of AVA X LP. Each of AVA X LP and AVA X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of its pecuniary interest therein, if any.
Footnote F8
The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is AVAO I LP. AVAO I LLC is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.